Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jun 1;101(11):2446–2455. doi: 10.1172/JCI2703

Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.

T G Markees 1, N E Phillips 1, E J Gordon 1, R J Noelle 1, L D Shultz 1, J P Mordes 1, D L Greiner 1, A A Rossini 1
PMCID: PMC508834  PMID: 9616216

Abstract

Treatment of C57BL/6 mice with one transfusion of BALB/c spleen cells and anti-CD154 (anti-CD40-ligand) antibody permits BALB/c islet grafts to survive indefinitely and BALB/c skin grafts to survive for approximately 50 d without further intervention. The protocol induces long-term allograft survival, but the mechanism is unknown. We now report: (a) addition of thymectomy to the protocol permitted skin allografts to survive for > 100 d, suggesting that graft rejection in euthymic mice results from thymic export of alloreactive T cells. (b) Clonal deletion is not the mechanism of underlying long-term graft survival, as recipient thymectomized mice were immunocompetent and harbor alloreactive T cells. (c) Induction of skin allograft acceptance initially depended on the presence of IFN-gamma, CTLA4, and CD4(+) T cells. Addition of anti-CTLA4 or anti-IFN-gamma mAb to the protocol was associated with prompt graft rejection, whereas anti-IL-4 mAb had no effect. The role of IFN-gamma was confirmed using knockout mice. (d) Graft survival was associated with the absence of IFN-gamma in the graft. (e) Long-term graft maintenance required the continued presence of CD4(+) T cells. The results suggest that, with modification, our short-term protocol may yield a procedure for the induction of long-term graft survival without prolonged immunosuppression.

Full Text

The Full Text of this article is available as a PDF (240.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azuma H., Chandraker A., Nadeau K., Hancock W. W., Carpenter C. B., Tilney N. L., Sayegh M. H. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12439–12444. doi: 10.1073/pnas.93.22.12439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BILLINGHAM R. E., BRENT L., MEDAWAR P. B. Actively acquired tolerance of foreign cells. Nature. 1953 Oct 3;172(4379):603–606. doi: 10.1038/172603a0. [DOI] [PubMed] [Google Scholar]
  3. Billiau A. Interferon-gamma in autoimmunity. Cytokine Growth Factor Rev. 1996 Jun;7(1):25–34. doi: 10.1016/1359-6101(96)00004-4. [DOI] [PubMed] [Google Scholar]
  4. Blazar B. R., Taylor P. A., Panoskaltsis-Mortari A., Buhlman J., Xu J., Flavell R. A., Korngold R., Noelle R., Vallera D. A. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol. 1997 Jan 1;158(1):29–39. [PubMed] [Google Scholar]
  5. Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749–795. doi: 10.1146/annurev.immunol.15.1.749. [DOI] [PubMed] [Google Scholar]
  6. Bushell A., Morris P. J., Wood K. J. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol. 1995 Sep;25(9):2643–2649. doi: 10.1002/eji.1830250936. [DOI] [PubMed] [Google Scholar]
  7. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994 Oct 1;180(4):1263–1272. doi: 10.1084/jem.180.4.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993 Mar 19;259(5102):1739–1742. doi: 10.1126/science.8456300. [DOI] [PubMed] [Google Scholar]
  10. Davis W. C., McKenzie I. F., Melvold R. W. A comparison of skin and heart graft rejection patterns in H-2 mutant mice. Transplantation. 1980 Mar;29(3):189–192. doi: 10.1097/00007890-198003000-00004. [DOI] [PubMed] [Google Scholar]
  11. De Fazio S. R., Masli S., Gozzo J. J. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells. Transplantation. 1996 Jan 15;61(1):104–110. doi: 10.1097/00007890-199601150-00021. [DOI] [PubMed] [Google Scholar]
  12. Durie F. H., Aruffo A., Ledbetter J., Crassi K. M., Green W. R., Fast L. D., Noelle R. J. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest. 1994 Sep;94(3):1333–1338. doi: 10.1172/JCI117453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Foy T. M., Shepherd D. M., Durie F. H., Aruffo A., Ledbetter J. A., Noelle R. J. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med. 1993 Nov 1;178(5):1567–1575. doi: 10.1084/jem.178.5.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hancock W. W., Sayegh M. H., Zheng X. G., Peach R., Linsley P. S., Turka L. A. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13967–13972. doi: 10.1073/pnas.93.24.13967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hanson M. S., Cetkovic-Cvrlje M., Ramiya V. K., Atkinson M. A., Maclaren N. K., Singh B., Elliott J. F., Serreze D. V., Leiter E. H. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol. 1996 Aug 1;157(3):1279–1287. [PubMed] [Google Scholar]
  16. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274. doi: 10.1016/0092-8674(93)80068-p. [DOI] [PubMed] [Google Scholar]
  17. Lakkis F. G., Konieczny B. T., Saleem S., Baddoura F. K., Linsley P. S., Alexander D. Z., Lowry R. P., Pearson T. C., Larsen C. P. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol. 1997 Mar 1;158(5):2443–2448. [PubMed] [Google Scholar]
  18. Larsen C. P., Elwood E. T., Alexander D. Z., Ritchie S. C., Hendrix R., Tucker-Burden C., Cho H. R., Aruffo A., Hollenbaugh D., Linsley P. S. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996 May 30;381(6581):434–438. doi: 10.1038/381434a0. [DOI] [PubMed] [Google Scholar]
  19. Larsen C. P., Steinman R. M., Witmer-Pack M., Hankins D. F., Morris P. J., Austyn J. M. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med. 1990 Nov 1;172(5):1483–1493. doi: 10.1084/jem.172.5.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Li H., Kaufman C. L., Ildstad S. T. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery. 1995 Aug;118(2):192–198. doi: 10.1016/s0039-6060(05)80323-x. [DOI] [PubMed] [Google Scholar]
  21. Lin H., Bolling S. F., Linsley P. S., Wei R. Q., Gordon D., Thompson C. B., Turka L. A. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med. 1993 Nov 1;178(5):1801–1806. doi: 10.1084/jem.178.5.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lu L., Rudert W. A., Qian S., McCaslin D., Fu F., Rao A. S., Trucco M., Fung J. J., Starzl T. E., Thomson A. W. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 1;182(2):379–387. doi: 10.1084/jem.182.2.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Markees T. G., Phillips N. E., Noelle R. J., Shultz L. D., Mordes J. P., Greiner D. L., Rossini A. A. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation. 1997 Jul 27;64(2):329–335. doi: 10.1097/00007890-199707270-00026. [DOI] [PubMed] [Google Scholar]
  24. Marshall S. E., Cobbold S. P., Davies J. D., Martin G. M., Phillips J. M., Waldmann H. Tolerance and suppression in a primed immune system. Transplantation. 1996 Dec 15;62(11):1614–1621. doi: 10.1097/00007890-199612150-00015. [DOI] [PubMed] [Google Scholar]
  25. Mayumi H., Good R. A. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med. 1989 Jan 1;169(1):213–238. doi: 10.1084/jem.169.1.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Metwali A., Elliott D., Blum A. M., Li J., Sandor M., Lynch R., Noben-Trauth N., Weinstock J. V. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J Immunol. 1996 Nov 15;157(10):4546–4553. [PubMed] [Google Scholar]
  27. Nash J. R., Peters M., Bell P. R. Comparative survival of pancreatic islets, heart, kidney, and skin allografts in rats, with and without enhancement. Transplantation. 1977 Jul;24(1):70–73. doi: 10.1097/00007890-197707000-00010. [DOI] [PubMed] [Google Scholar]
  28. Nickerson P., Zheng X. X., Steiger J., Steele A. W., Steurer W., Roy-Chaudhury P., Müller W., Strom T. B. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transpl Immunol. 1996 Mar;4(1):81–85. doi: 10.1016/s0966-3274(96)80043-8. [DOI] [PubMed] [Google Scholar]
  29. Noelle R. J., Roy M., Shepherd D. M., Stamenkovic I., Ledbetter J. A., Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6550–6554. doi: 10.1073/pnas.89.14.6550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Onodera K., Chandraker A., Schaub M., Stadlbauer T. H., Korom S., Peach R., Linsley P. S., Sayegh M. H., Kupiec-Weglinski J. W. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. J Immunol. 1997 Aug 15;159(4):1711–1717. [PubMed] [Google Scholar]
  31. Parker D. C., Greiner D. L., Phillips N. E., Appel M. C., Steele A. W., Durie F. H., Noelle R. J., Mordes J. P., Rossini A. A. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9560–9564. doi: 10.1073/pnas.92.21.9560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pearson T. C., Alexander D. Z., Winn K. J., Linsley P. S., Lowry R. P., Larsen C. P. Transplantation tolerance induced by CTLA4-Ig. Transplantation. 1994 Jun 27;57(12):1701–1706. [PubMed] [Google Scholar]
  33. Perez V. L., Van Parijs L., Biuckians A., Zheng X. X., Strom T. B., Abbas A. K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 1997 Apr;6(4):411–417. doi: 10.1016/s1074-7613(00)80284-8. [DOI] [PubMed] [Google Scholar]
  34. Pham S. M., Keenan R. J., Rao A. S., Fontes P. A., Kormos R. L., Abu-Elmagd K., Zeevi A., Kawai A., Hattler B. G., Hardesty R. L. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg. 1995 Oct;60(4):1015–1020. doi: 10.1016/0003-4975(95)00579-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Posselt A. M., Naji A., Barker C. F. Microchimerism of the thymus and graft acceptance. Lancet. 1992 Sep 5;340(8819):617–617. doi: 10.1016/0140-6736(92)92158-c. [DOI] [PubMed] [Google Scholar]
  36. Presky D. H., Yang H., Minetti L. J., Chua A. O., Nabavi N., Wu C. Y., Gately M. K., Gubler U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14002–14007. doi: 10.1073/pnas.93.24.14002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Péguet-Navarro J., Dalbiez-Gauthier C., Rattis F. M., Van Kooten C., Banchereau J., Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol. 1995 Nov 1;155(9):4241–4247. [PubMed] [Google Scholar]
  38. Qin S., Cobbold S. P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. "Infectious" transplantation tolerance. Science. 1993 Feb 12;259(5097):974–977. doi: 10.1126/science.8094901. [DOI] [PubMed] [Google Scholar]
  39. Rossini A. A., Parker D. C., Phillips N. E., Durie F. H., Noelle R. J., Mordes J. P., Greiner D. L. Induction of immunological tolerance to islet allografts. Cell Transplant. 1996 Jan-Feb;5(1):49–52. doi: 10.1177/096368979600500109. [DOI] [PubMed] [Google Scholar]
  40. Russell M. E., Hancock W. W., Akalin E., Wallace A. F., Glysing-Jensen T., Willett T. A., Sayegh M. H. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest. 1996 Feb 1;97(3):833–838. doi: 10.1172/JCI118483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schwadron R. B., Dittmer J. E., Hartnett L. C. The effect of class I and class II alloantigens on skin allograft acceptance by lethally irradiated rats repopulated with syngeneic bone marrow. Transplantation. 1985 May;39(5):558–560. [PubMed] [Google Scholar]
  42. Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science. 1990 Jun 15;248(4961):1349–1356. doi: 10.1126/science.2113314. [DOI] [PubMed] [Google Scholar]
  43. Slavin S., Strober S., Fuks Z., Kaplan H. S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med. 1977 Jul 1;146(1):34–48. doi: 10.1084/jem.146.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sprent J., Hurd M., Schaefer M., Heath W. Split tolerance in spleen chimeras. J Immunol. 1995 Feb 1;154(3):1198–1206. [PubMed] [Google Scholar]
  45. Starzl T. E., Demetris A. J., Murase N., Thomson A. W., Trucco M., Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today. 1993 Jun;14(6):326–332. doi: 10.1016/0167-5699(93)90054-o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Starzl T. E., Demetris A. J., Murase N., Trucco M., Thomson A. W., Rao A. S. The lost chord: microchimerism and allograft survival. Immunol Today. 1996 Dec;17(12):577–588. doi: 10.1016/s0167-5699(96)10070-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Steurer W., Nickerson P. W., Steele A. W., Steiger J., Zheng X. X., Strom T. B. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol. 1995 Aug 1;155(3):1165–1174. [PubMed] [Google Scholar]
  48. Sykes M., Sachs D. H. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today. 1988 Jan;9(1):23–27. doi: 10.1016/0167-5699(88)91352-7. [DOI] [PubMed] [Google Scholar]
  49. Szabo S. J., Dighe A. S., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med. 1997 Mar 3;185(5):817–824. doi: 10.1084/jem.185.5.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tivol E. A., Boyd S. D., McKeon S., Borriello F., Nickerson P., Strom T. B., Sharpe A. H. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol. 1997 Jun 1;158(11):5091–5094. [PubMed] [Google Scholar]
  51. Wood M. L., Gottschalk R., Monaco A. P. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice. Transplantation. 1988 Sep;46(3):449–451. [PubMed] [Google Scholar]
  52. Yamada K., Gianello P. R., Ierino F. L., Lorf T., Shimizu A., Meehan S., Colvin R. B., Sachs D. H. Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I-mismatched renal allografts. J Exp Med. 1997 Aug 18;186(4):497–506. doi: 10.1084/jem.186.4.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Yin D. P., Sankary H. N., Williams J., Krieger N., Fathman C. G. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. Transplantation. 1996 Dec 15;62(11):1537–1539. doi: 10.1097/00007890-199612150-00001. [DOI] [PubMed] [Google Scholar]
  54. Young H. A., Hardy K. J. Role of interferon-gamma in immune cell regulation. J Leukoc Biol. 1995 Oct;58(4):373–381. [PubMed] [Google Scholar]
  55. Zheng X. X., Sayegh M. H., Zheng X. G., Li Y., Linsley P. S., Peach R., Borriello F., Strom T. B., Sharpe A. H., Turka L. A. The role of donor and recipient B7-1 (CD80) in allograft rejection. J Immunol. 1997 Aug 1;159(3):1169–1173. [PubMed] [Google Scholar]
  56. Zipris D., Greiner D. L., Malkani S., Whalen B., Mordes J. P., Rossini A. A. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol. 1996 Feb 1;156(3):1315–1321. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES